Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Unknown 1Enrolling by invitation 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gynecologic 89Genitourinary 49Sarcoma 19Gastrointestinal 15Breast 14Thoracic 4Head & Neck 4CNS 4Tumor-Agnostic 2Other solid neoplasm 2Dermatologic 2Classical hematology 2Other neoplasm 1Other 1

Conditions

Uveal Melanoma 2Uveitis 1Melanoma 1Choroid Neoplasms 1

Interventions

pembrolizumab 326Nivolumab 289Ipilimumab 260Cyclophosphamide 193aldesleukin 145Interleukin-2 109fludarabine phosphate 106Temozolomide 83Dacarbazine 81fludarabine 80Radiotherapy 74trametinib 73Vemurafenib 69dabrafenib 66Biopsy 65sargramostim 50Bevacizumab 50Radiosurgery 49Paclitaxel 49Peripheral Blood Stem Cell Transplantation 48Carboplatin 48Magnetic Resonance Spectroscopy 47Imiquimod 47Aminolevulinic Acid 47binimetinib 45Cisplatin 45CTLA-4 Antigen 43cemiplimab 42atezolizumab 41Specimen Handling 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Brachytherapy × Dermatologic × Clear all
NCT05893654 2025-09-15

MELCOM

Hospital das Clínicas de Ribeirão Preto

Phase 1/2 Enrolling by invitation
10 enrolled
Dermatologic

Uveal Melanoma, Melanoma

NCT00000124 2006-06-02

Collaborative Ocular Melanoma Study (COMS)

National Eye Institute (NEI)

Phase 3 Unknown
Dermatologic

Uveal Melanoma, Choroid Neoplasms, Uveitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡